Search Results

• • 4,953 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Select 2F Hyperlipoproteinemias

  1

  2F Hyperlipoproteinemias

  From:Nurse Practitioners' Prescribing Reference (Vol. 20, Issue 2) Peer-Reviewed

  Summer 20138,056 words Drug overview 880LADVICOR AbbVie Rx Nicotinic acid deriv. + HMG-CoA reductase inhibitor. Niacin ext-rel, lovastatin; 500mg/20mg, 750mg/20mg, 1000mg/20mg, 1000mg/40mg; tabs. Indications: Adjunct to diet in primary...
• Select 2F Hyperlipoproteinemias

  2

  2F Hyperlipoproteinemias

  From:Nurse Practitioners' Prescribing Reference (Vol. 20, Issue 1) Peer-Reviewed

  Spring 20137,552 words Drug overview 870LADVICOR Abbott Rx Nicotinic acid deriv. + HMG-CoA reductase inhibitor. Niacin ext-rel, lovastatin; 500mg/20mg, 750mg/20mg, 1000mg/20mg, 1000mg/40mg; tabs. Indications: Adjunct to diet in primary...
• Select Statins may reduce mortality in hepatocellular cancer

  3

  Statins may reduce mortality in hepatocellular cancer

  Author:Sherry BoschertFrom:Internal Medicine News (Vol. 46, Issue 4)

  Mar. 1, 2013557 words Article 1320LAT THE ASCO GASTROINTESTINAL CANCERS SYMPOSIUM SAN FRANCISCO--The use of statins may reduce the risk of death in patients with hepatocellular cancer by 30%, a retrospective study of 639 patients suggests. Median...
• Select Statin sensitive lipid-retinopathy in familial hypercholesterolemia

  4

  Statin sensitive lipid-retinopathy in familial hypercholesterolemia

  Authors:Aysha Salam, Prasad Palimar, and Alison DavisFrom:Journal of Clinical Ophthalmology and Research (Vol. 1, Issue 3) Peer-Reviewed

  September-December 20131,277 words Case study 1550LByline: Aysha. Salam, Prasad. Palimar, Alison. Davis An asymptomatic 9-year-old boy was referred for extensive lipid exudation into the retina. He was known to have familial hypercholesterolemia. The lipids resorbed...
• Select Pharmacological lipid lowering for prevention of cardiovascular disease in older adults

  5

  Pharmacological lipid lowering for prevention of cardiovascular disease in older adults

  Authors:Olov Wiklund, Carlo Pirazzi, and Stefano RomeoFrom:Clinical Practice (Vol. 11, Issue 1) Peer-Reviewed

  Jan. 20146,682 words Report 1380LAuthor(s): Olov Wiklund [*] 2 , Carlo Pirazzi 1 , Stefano Romeo 1 Practice Points * Dyslipidemia is a risk factor for cardiovascular disease (CVD) in older adults. * Statin treatment should always be considered...
• Select Statin-associated acute interstitial nephritis and rhabdomyolysis

  6

  Statin-associated acute interstitial nephritis and rhabdomyolysis

  Author:Vidyashankar PanchangamFrom:Saudi Journal of Kidney Diseases and Transplantation (Vol. 25, Issue 3) Peer-Reviewed

  May-June 2014871 words Letter to the editor 1470LByline: Vidyashankar. Panchangam To the Editor, Statin therapy has proven to be safe and well tolerated in millions of patients over a decade of time, and statin-associated myopathy is a well-known fact. The use...
• Select Recent Findings from Queen Mary University Provides New Insights into Cardiovascular Diseases (Statin prescribing for primary prevention of cardiovascular disease: a cross-sectional, observational study)

  7

  Recent Findings from Queen Mary University Provides New Insights into Cardiovascular Diseases (Statin prescribing for primary prevention of cardiovascular disease: a cross-sectional, observational study)

  From:Obesity, Fitness & Wellness Week

  Aug. 29, 2015382 words Report 1490L2015 AUG 29 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Fresh data on Cardiovascular Diseases are presented in a new report. According to news originating from London, United...
• Select Statins cost-effective in adults aged 40-75 years

  8

  Statins cost-effective in adults aged 40-75 years

  From:Clinical Advisor (Vol. 18, Issue 9)

  Sept. 2015205 words Brief article 1620LTREATMENT WITH statins is cost-effective for 48% to 67% of all adults aged 40 years to 75 years, based on the 2013 American College of Cardiology/American Heart Association (ACC/AHA) guidelines, according to a study...
• Select New Fatty Liver Study Results Reported from Aristotle University (Nonalcoholic fatty liver disease and statins)

  9

  New Fatty Liver Study Results Reported from Aristotle University (Nonalcoholic fatty liver disease and statins)

  From:Obesity, Fitness & Wellness Week

  Oct. 24, 2015356 words Brief article 1360L2015 OCT 24 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Liver Diseases and Conditions have been published. According to news originating from...
• Select New Clinical Trials and Studies Data Have Been Reported by Investigators at University of Amsterdam (Expanding the Evidence Base: Comparing Randomized Controlled Trials and Observational Studies of Statins)

  10

  New Clinical Trials and Studies Data Have Been Reported by Investigators at University of Amsterdam (Expanding the Evidence Base: Comparing Randomized Controlled Trials and Observational Studies of Statins)

  From:Obesity, Fitness & Wellness Week

  Oct. 17, 2015385 words Brief article 1570L2015 OCT 17 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on Clinical Research have been presented. According to news reporting originating in Amsterdam,...
• Select Lancet: Vascular protection from statins continues to accrue

  11

  Lancet: Vascular protection from statins continues to accrue

  From:Medical Economics (Vol. 89, Issue 3)

  Feb. 10, 2012135 words Brief article, Repri... 1510LSimvastatin treatment continues to reduce the risk of cardiovascular events in high-risk individuals for at least 5 years after stopping therapy without evidence of harm, according to investigators from the Heart...
• Select Research Conducted at Institute of Pharmacy Has Updated Our Knowledge about Cardiovascular Research

  12

  Research Conducted at Institute of Pharmacy Has Updated Our Knowledge about Cardiovascular Research

  From:Obesity, Fitness & Wellness Week

  June 2, 2012441 words Article 1510LBy a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on Cardiovascular Research have been presented. According to news originating from Sirsa, India, by NewsRx correspondents,...
• Select Statins reduce cardiovascular events in OA and RA

  13

  Statins reduce cardiovascular events in OA and RA

  From:The Journal of Musculoskeletal Medicine (Vol. 29, Issue 2) Peer-Reviewed

  Mar. 2012239 words Brief article 1320LStatins help reduce total cholesterol (TC) concentrations in patients with osteoarthritis (OA) or rheumatoid arthritis (RA). The use of statins is associated with reduced cardiovascular (CV) events and mortality in...
• Select PSA levels decline after the start of statin therapy

  14

  PSA levels decline after the start of statin therapy

  From:Renal & Urology News (Vol. 9, Issue 1)

  Jan. 2010151 words Brief article 1380LOnset of statin use is associated with a significant reduction in serum PSA level, data suggest. David J. Mener, MD, and colleagues at the University of Rochester/Strong Memorial Hospital in Rochester, N.Y., used...
• Select Higher HDL-C Concentrations May Not Always Be a Good Measure of Heart Risk

  15

  Higher HDL-C Concentrations May Not Always Be a Good Measure of Heart Risk

  From:Obesity, Fitness & Wellness Week

  Sept. 11, 2010489 words Article 1390LPeople with high levels of "good cholesterol," HDL-C, tend to have fewer heart attacks, but HDL-C may offer little protection to people who take statins to lower harmful LDL cholesterol, researchers reported July 21. At...
• Select PCa less adverse in statin users

  16

  PCa less adverse in statin users

  From:Renal & Urology News (Vol. 9, Issue 5)

  May 201093 words Brief article 1480LPROSTATE CANCER (PCa) patients who use statins may have a lower rate of adverse tumor pathology features than nonusers, according to findings published in BJU International (2010;105:1222-1225). William Catalona, MD,...
• Select Statin use linked to 57% reduction in knee OA incidence

  17

  Statin use linked to 57% reduction in knee OA incidence

  Author:Mitchel L. ZolerFrom:Family Practice News (Vol. 40, Issue 19)

  Nov. 15, 2010404 words Clinical report 1620LFROM THE WORLD CONGRESS ON OSTEOARTHRITIS BRUSSELS -- Statin therapy may exert yet another beneficial clinical effect--preventing the development of knee osteoarthritis and slowing its progression--based on an...
• Select Levels of 'good' cholesterol less relevant to cardiovascular risk once 'bad' cholesterol has been reduced by treatment with statins

  18

  Levels of 'good' cholesterol less relevant to cardiovascular risk once 'bad' cholesterol has been reduced by treatment with statins

  From:Obesity, Fitness & Wellness Week

  Aug. 7, 2010479 words Report 1660LIn the general population, the more 'good' cholesterol* that a person has, the less likely they are to suffer a cardiovascular event. But new research shows that if a person has their levels of 'bad' cholesterol* *...
• Select Statins for all--with established cardiovascular risk factors

  19

  Statins for all--with established cardiovascular risk factors

  Author:Bridget FarhamFrom:CME: Your SA Journal of CPD (Vol. 27, Issue 8) Peer-Reviewed

  Aug. 2009250 words Brief article, Repor... 1300LA team of investigators from multiple centres have used published papers to show that statins are beneficial for people without cardiovascular disease, but who have established cardiovascular risk factors. The team...
• Select Statins may cut AD risk, even in ApoE4 carriers

  20

  Statins may cut AD risk, even in ApoE4 carriers

  Author:Michele G. SullivanFrom:Clinical Psychiatry News (Vol. 37, Issue 4)

  Apr. 2009309 words Brief article, Clini... 1070LStatins appear to cut the risk of developing Alzheimer's disease by up to 56%, even in those with the high-risk apolipoprotein E4 allele. The link between statin use and risk reduction was consistent for lipophilic...